Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China · Delayed Price · Currency is CNY 14.03
-0.19 (-1.34%)
Mar 26, 2026, 3:04 PM CST
Cachet Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 111.38 | 158.14 | 250.06 | 296.94 | 353.88 |
Depreciation & Amortization | 86.26 | 126.54 | 202.14 | 227 | 201.09 |
Other Amortization | 18.64 | 31.93 | 78.82 | 53.45 | 31.25 |
Loss (Gain) From Sale of Assets | -4.31 | -201.43 | -0.85 | -1.67 | -0.74 |
Asset Writedown & Restructuring Costs | 49.13 | 86.56 | 40.35 | 22.09 | 13.92 |
Loss (Gain) From Sale of Investments | -3.57 | 0.01 | -0.07 | -0.15 | -1.02 |
Provision & Write-off of Bad Debts | 247.07 | 95.61 | 84.55 | 77.03 | 26.36 |
Other Operating Activities | 145.84 | 304.69 | 370.99 | 378.21 | 421.93 |
Change in Accounts Receivable | 914.35 | 2,126 | -601.58 | -2,438 | -655.15 |
Change in Inventory | 224.22 | -125.09 | 72.78 | -510.71 | -179.78 |
Change in Accounts Payable | -397.95 | -2,439 | 1,130 | 1,766 | 704.67 |
Change in Other Net Operating Assets | - | - | - | - | 0.25 |
Operating Cash Flow | 1,392 | 180.36 | 1,595 | -163.45 | 913.13 |
Operating Cash Flow Growth | 671.92% | -88.70% | - | - | -18.10% |
Capital Expenditures | -22.79 | -15.42 | -199.3 | -188.53 | -246.96 |
Sale of Property, Plant & Equipment | 1.95 | 463.27 | 6.19 | 5.79 | 3.74 |
Cash Acquisitions | - | - | - | -1.58 | - |
Divestitures | 19.58 | 10.62 | 4.19 | -2.02 | - |
Investment in Securities | -4.7 | -90.46 | 3.52 | 10.9 | -16.24 |
Other Investing Activities | 0.23 | - | 0.14 | - | 2.33 |
Investing Cash Flow | -5.74 | 368 | -185.25 | -175.44 | -257.13 |
Short-Term Debt Issued | 2,303 | 3,243 | 5,179 | 5,052 | 4,242 |
Total Debt Issued | 2,303 | 3,243 | 5,179 | 5,052 | 4,242 |
Short-Term Debt Repaid | -3,111 | -3,933 | -5,400 | -4,779 | -4,105 |
Long-Term Debt Repaid | -74.52 | -81.9 | -77.33 | -69.48 | -61.85 |
Total Debt Repaid | -3,185 | -4,014 | -5,477 | -4,848 | -4,167 |
Net Debt Issued (Repaid) | -882.44 | -771.8 | -298.08 | 203.87 | 75.76 |
Repurchase of Common Stock | -6.54 | -10 | - | - | - |
Common Dividends Paid | -108.87 | -167.57 | -214.34 | -282.31 | -242.66 |
Other Financing Activities | -55.24 | 44.66 | -119.07 | -84.39 | -166.23 |
Financing Cash Flow | -1,053 | -904.71 | -631.49 | -162.83 | -333.12 |
Foreign Exchange Rate Adjustments | - | - | - | - | -0.66 |
Net Cash Flow | 333.37 | -356.35 | 778.7 | -501.72 | 322.22 |
Free Cash Flow | 1,369 | 164.93 | 1,396 | -351.98 | 666.17 |
Free Cash Flow Growth | 730.29% | -88.19% | - | - | -22.26% |
Free Cash Flow Margin | 7.01% | 0.69% | 4.65% | -1.34% | 2.60% |
Free Cash Flow Per Share | 4.67 | 0.56 | 4.80 | -1.21 | 2.28 |
Cash Interest Paid | 2.72 | 4.29 | 2.01 | - | - |
Cash Income Tax Paid | 361.49 | 594.37 | 423.62 | 483.51 | 557.46 |
Levered Free Cash Flow | 1,538 | 642.66 | 1,161 | -79.27 | 359.36 |
Unlevered Free Cash Flow | 1,590 | 723.4 | 1,265 | 38.59 | 462.01 |
Change in Working Capital | 741.77 | -421.68 | 569.43 | -1,216 | -133.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.